Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 27 pseudogene (RNU7-27P), also known as U7.27 and RNA, small nuclear U7.27 pseudogene, refers to a pseudogene related to the functional U7 small nuclear RNA, but does not itself encode a functional product[5]. The RNA, U7 small nuclear 27 pseudogene (RNU7-27P) is a genomic sequence that resembles the gene encoding U7 small nuclear RNA but does not produce a functional product[5]. Functional U7 snRNA is a component of the U7 small nuclear ribonucleoprotein complex, which is essential for histone pre-mRNA processing[3][4]. However, RNU7-27P being a pseudogene, is considered biologically inactive and does not contribute to any known cellular or disease processes[5]. Pseudogenes typically arise from duplication or mutation of functional genes and are not expressed as functional RNA or protein. RNU7-27P is not a validated target for drugs or therapeutic interventions due to its pseudogene nature[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 27 pseudogene (RNU7-27P).